scispace - formally typeset
M

Maria Winnock

Researcher at French Institute of Health and Medical Research

Publications -  65
Citations -  1711

Maria Winnock is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Population & Hepatitis C virus. The author has an hindex of 24, co-authored 65 publications receiving 1656 citations. Previous affiliations of Maria Winnock include University of Bordeaux.

Papers
More filters
Journal ArticleDOI

Epidemiology of liver disease in cystic fibrosis: a longitudinal study

TL;DR: This study shows that CF related-liver disease occurs mainly in the first decade of life with a prevalence of 41% of patients at 12 years of age, and a history of meconium ileus and pancreatic insufficiency are predictive of liver disease.
Journal ArticleDOI

Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients.

TL;DR: In patients with liver cirrhosis, MRI is more accurate than spiral computed tomography for the detection of liver nodules and dysplastic nodules, however, tumour size is always a restricting factor for these two techniques, which are unable to detect small HCC in more than 60% of cases.
Journal ArticleDOI

Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver

TL;DR: In patients with HCC in NCL and iron overload, C282Y mutations are frequent (36.8% of cases) and significantly increased compared to HCCIn NCL without iron overload; these mutations are mostly heterozygous.
Journal ArticleDOI

Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.

TL;DR: The use of these noninvasive indexes could save liver biopsies in up to 56–76% of cases for the prediction of severe fibrosis-cirrhosis, but given the high percentage of misclassified cases for significant fibrosis, such indexes do not appear currently suitable for use in clinical practice in HIV-HCV-coinfected patients.